Top

Global Inflammatory Bowel Disease Market 2015-2019

Category : Pharmaceuticals  | Published Date : Apr-2015 | Pages : 146
enquire GET DISCOUNT

About Inflammatory Bowel Disease
Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management.  The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors.

TechNavio's analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Inflammatory Bowel Disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of inflammatory bowel disease. The market includes data from the sales of various drusg which are used for the treatment of Crohn's Disease and Ulcerative Colitis.

On the basis of the functioning of the drugs used for treatment, the Global Inflammatory Bowel Disease market is categorized into three segments.

• 5-ASA
• Antibiotics
• Immunomodulators
On the basis of the type of molecule used for treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.

• Biologics
• Small Molecules
On the basis of route of administration adopted for the treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.
• Oral
• Parenteral

On the basis of the form of drug used to treat the disease, the Global Inflammatory Bowel Disease market is categorized into two segments.

• Solid
• Liquid
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Inflammatory Bowel Disease market. The vendor landscape includes an analysis of the major vendors, along with the competitive performances of their portfolios. In addition, the report discusses the major drivers, challenges and trends influencing the market. In addition, late-stage pipeline molecules developed for the treatment of inflammatory bowel disease are discussed.

TechNavio's report, Global Inflammatory Bowel Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the landscape of the Global Inflammatory Bowel Disease market and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA    
   
Key Vendors
• Abbvie
• Biogen Idec
• Janssen Pharmaceuticals
• Merck & Company
• Shire
• UCB 

Other Prominent Vendors
 • Amgen
• Akebia Therapeutics
• Boehringer Ingelheim
• Celltrion
• ChemoCentryx
• Ferring Pharmaceuticals
• Galapagos
• Genentech
• Merck
• Mitsubishi Tanabe
• Novartis
• Novo Nordisk
• Pfizer
• Salix Pharmaceuticals

Market Driver
• Increase in Instances of Inflammatory Bowel Disease
• For a full, detailed list, view our report

Market Challenge
• High Cost of Drugs
• For a full, detailed list, view our report

Market Trend
• Dominance of Market by Biologics
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?



01. Executive Summary



02. List of Abbreviations



03. Scope of the Report



03.1 Market Overview



03.2 Product Offerings



04. Market Research Methodology



04.1 Market Research Process



04.2 Research Methodology



05. Introduction



06. Disease Overview: Crohn's Disease



06.1 Understanding the Disease



06.2 Etiology



06.2.1 Autoimmune Reaction



06.2.2 Genes



06.2.3 Environment



06.3 Stages of Crohn's disease



06.4 Epidemiology



06.4.1 Worldwide Prevalence of Crohn's Disease



06.4.2 US



06.4.3 UK



06.5 Symptoms



06.5.1 Diarrhea



06.5.2 Fever and Fatigue



06.5.3 Abdominal Pain and Cramping



06.5.4 Perianal Disease and Blood in Stool



06.5.5 Reduced Appetite and Weight Loss



06.6 Diagnosis and Testing



06.6.1 Early Tests and Exams



06.6.2 Endoscopy and Biopsy



06.6.3 Chromoendoscopy



06.6.4 Small Intestinal Imaging



06.7 Treatment



06.7.1 Medication



06.7.2 Diet and Nutrition



06.7.3 Surgery



07. Disease Overview: Ulcerative Colitis



07.1 Understanding the Disease



07.2 Etiology



07.2.1 Autoimmune Reaction



07.2.2 Genetics



07.2.3 Environmental Factors



07.3 Prognosis



07.4 Epidemiology



07.4.1 Global



07.4.2 UK



07.4.3 US



07.5 Symptoms



07.6 Diagnosis and Testing



07.7 Treatment



07.7.1 Medical Treatment Options



07.7.2 Surgical Procedures



08. Pipeline Portfolio



08.1 Crohn's Disease Pipeline Landscape



08.1.1 Some Emerging Therapeutic Options



08.2 Ulcerative Colitis Pipeline Landscape



09. Market Landscape



09.1 Global Inflammatory Bowel Disease Market



09.2 Market Size and Forecast



09.3 Inflammatory Bowel Disease Market in US



09.3.1 Market Size and Forecast



09.4 Inflammatory Bowel Disease Market in 5EU



09.4.1 Market Size and Forecast



09.5 Inflammatory Bowel Disease Market in Japan



09.5.1 Market Size and Forecast



10. Market Segmentation by Type of Disease



10.1 Crohn's Disease



10.2 Ulcerative Colitis



11. Global Crohn's Disease Market



11.1 Market Size and Forecast



11.2 Crohn's Disease Market in US



11.2.1 Market Size and Forecast



11.3 Crohn's Disease Market in Japan



11.3.1 Market Size and Forecast



12. Global Ulcerative Colitis Market



12.1 Market Size and Forecast



12.2 Five Forces Analysis



13. Market Segmentation by Drug Class



14. Market Segmentation by Type of Molecules



14.1 Biologics



14.2 Small Molecules



15. Market Segmentation by Dosage Form



15.1 Solid



15.2 Liquid



16. Market Segmentation by Route of Administration



16.1 Oral



16.2 Parenteral



17. Geographical Segmentation



17.1 Geographic Segmentation of Global Crohn's Disease Market



17.2 Geographic Segmentation of Global Ulcerative Colitis Market



18. Key Leading Countries



18.1 Key Leading Countries 2014



18.2 Key Leading Countries 2019



18.3 US



18.4 Japan



19. Buying Criteria



20. Market Growth Drivers



21. Drivers and their Impact



22. Market Challenges



23. Impact of Drivers and Challenges



24. Market Trends



25. Trends and their Impact



26. Vendor Landscape



26.1 Competitive Scenario



26.1.1 Key News



26.1.2 Mergers and Acquisitions



26.2 Market Share Analysis 2014



26.2.1 Competitive Assessment of Top Drugs for Inflammatory Bowel Disease



26.2.2 Abbvie



26.2.3 Janssen Pharmaceuticals



26.2.4 Merck



26.2.5 Biogen Idec



26.2.6 UCB



26.2.7 Shire



26.3 Other and Future Prominent Vendors



27. Key Vendor Analysis



27.1 AbbVie Inc.



27.1.1 Key Facts



27.1.2 Business Overview



27.1.3 Product Segmentation by Revenue 2013



27.1.4 Product Segmentation by Revenue 2012 and 2013



27.1.5 Sales by Geography



27.1.6 Business Strategy



27.1.7 Key Developments



27.1.8 SWOT Analysis



27.2 Biogen Idec



27.2.1 Key Facts



27.2.2 Business Overview



27.2.3 Business Segmentation by Revenue 2013



27.2.4 Geographical Segmentation by Revenue 2013



27.2.5 Business Strategy



27.2.6 Key Developments



27.2.7 SWOT Analysis



27.3 Janssen Pharmaceuticals



27.3.1 Key Facts



27.3.2 Business Overview



27.3.3 Recent Developments



27.3.4 SWOT Analysis



27.4 Merck



27.4.1 Key Facts



27.4.2 Business Overview



27.4.3 Business Segmentation by Revenue 2013



27.4.4 Business Segmentation by Revenue 2012 and 2013



27.4.5 Sales by Geography



27.4.6 Business Strategy



27.4.7 Key Developments



27.4.8 SWOT Analysis



27.5 Shire



27.5.1 Key Facts



27.5.2 Business Overview



27.5.3 Geographical Segmentation by Revenue 2013



27.5.4 Business Strategy



27.5.5 Recent Developments



27.5.6 SWOT Analysis



27.6 UCB



27.6.1 Key Facts



27.6.2 Business Overview



27.6.3 Product Segmentation by Revenue 2013



27.6.4 Product Segmentation by Revenue 2012 and 2013



27.6.5 Geographical Segmentation by Revenue 2013



27.6.6 Business Strategy



27.6.7 Recent Developments



27.6.8 SWOT Analysis



28. Other Reports in this Series






List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Drivers and Challenges of the Global Inflammatory Bowel Disease Market

Exhibit 3: Overview of Crohn's disease

Exhibit 4: Classification of Crohn's disease

Exhibit 5: Expected Number of Global Crohn's Disease Cases 2015-2022

Exhibit 6: Global Variation in Incidence Rates for Crohn's Disease in 2012 (percent)

Exhibit 7: Prevalence of Crohn's Disease in US

Exhibit 8: Incidence of Crohn's Disease in US

Exhibit 9: Symptoms of Crohn's Disease

Exhibit 10: Crohn's Disease: Diagnosis and Testing

Exhibit 11: Crohn's Disease: Treatment

Exhibit 12: Treatment Landscape for Crohn's Disease

Exhibit 13: Crohn's Disease: Treatment Pathway

Exhibit 14: Ulcerative Colitis: Symptoms

Exhibit 15: Diagnostic Approach for Ulcerative Colitis

Exhibit 16: Treatment Options for Inflammatory Bowel Disease

Exhibit 17: Surgical procedure to treat Ulcerative Colitis

Exhibit 18: Crohn's Disease: Pipeline Portfolio

Exhibit 19: Crohn's Disease Clinical Trial by Phase

Exhibit 20: Crohn's Disease Clinical Trial by Status

Exhibit 21: Crohn's Disease: Pipeline Portfolio

Exhibit 22: Snapshot of Global Inflammatory Bowel Disease Market 2014

Exhibit 23: Global Inflammatory Bowel Disease Market 2014-2019 (US$ million)

Exhibit 24: Inflammatory Bowel Disease Market in US 2014-2019 (US$ million)

Exhibit 25: Inflammatory Bowel Disease Market in 5EU 2014-2019 (US$ million)

Exhibit 26: Inflammatory Bowel Disease Market in Japan 2014-2019 (US$ million)

Exhibit 27: Segmentation of Global Inflammatory Bowel Disease Market by Type of Disease

Exhibit 28: Segmentation of Global Inflammatory Bowel Disease Market by Type of Disease 2014

Exhibit 29: Segmentation of Global Inflammatory Bowel Disease Market by Type of Disease 2019

Exhibit 30: Revenue Comparison of Global Inflammatory Bowel Disease Market (Crohn's Disease and Ulcerative Colitis) 2014-2019 (US$ million)

Exhibit 31: Snapshot of Global Crohn's Disease Market 2014

Exhibit 32: Global Crohn's Disease Market 2014-2019 (US$ million)

Exhibit 33: Crohn's Disease Market in US 2014-2019 (US$ million)

Exhibit 34: Crohn's Disease Market in Japan 2014-2019 (US$ million)

Exhibit 35: Snapshot of the Global Ulcerative Colitis Market

Exhibit 36: Global Ulcerative Colitis Market 2014-2019 (US$ million)

Exhibit 37: Segmentation of Global Inflammatory Bowel Disease Market by Drug Class

Exhibit 38: Benefits and Risks of 5-ASA

Exhibit 39: Segmentation of Global Inflammatory Bowel Disease Market by Drug Class 2014

Exhibit 40: Segmentation of Global Inflammatory Bowel Disease Market by Type of Molecules

Exhibit 41: Segmentation of Global Inflammatory Bowel Disease Market by Type of Molecules 2014

Exhibit 42: Segmentation of Global Inflammatory Bowel Disease Market by Dosage Form

Exhibit 43: Segmentation of Global Inflammatory Bowel Disease Market by Dosage Form 2014

Exhibit 44: Segmentation of Global Inflammatory Bowel Disease Market by Route of Administration

Exhibit 45: Segmentation of Global Inflammatory Bowel Disease Market by Route of Administration 2014

Exhibit 46: Segmentation of Global Inflammatory Bowel Disease Market by Geography 2014

Exhibit 47: Segmentation of Global Inflammatory Bowel Disease Market by Geography 2019

Exhibit 48: Segmentation of Global Crohn's Disease Market by Geography 2014

Exhibit 49: Segmentation of Global Ulcerative Colitis Market by Geography 2014

Exhibit 50: Global Inflammatory Bowel Disease Market Share Analysis 2014

Exhibit 51: YoY Revenue Comparison of Top Drugs for Inflammatory Bowel Disease 2010-2014 (US$ million)

Exhibit 52: Revenue Share of Top Drugs for Inflammatory Bowel Disease 2010-2014 (in percentage)

Exhibit 53: Abbvie: Product Portfolio for Inflammatory Bowel Disease

Exhibit 54: YoY Global Revenue of Humira 2009-2014 (US$ million)

Exhibit 55: YoY Revenue of Humira in US 2009-2014 (US$ million)

Exhibit 56: YoY International Revenue of Humira (Except US) 2009-2014 (US$ million)

Exhibit 57: Global Revenue Comparison of Humira 2009-2014 (US$ million)

Exhibit 58: Janssen: Product Portfolio for Inflammatory Bowel Disease

Exhibit 59: YoY Global Revenue of Remicade 2009-2014 (US$ million)

Exhibit 60: YoY Global Revenue of Simponi 2010-2014 (US$ million)

Exhibit 61: Merck: Product Portfolio for Inflammatory Bowel Disease

Exhibit 62: YoY Global Revenue of Remicade 2009-2014 (US$ million)

Exhibit 63: YoY Global Revenue of Simponi 2010-20134(US$ million)

Exhibit 64: Biogen Idec: Product Portfolio for Inflammatory Bowel Disease

Exhibit 65: YoY Global Revenue of Tysabri 2009-2014 (US$ million)

Exhibit 66: YoY Revenue of Tysabri in US 2009-2014 (US$ million)

Exhibit 67: YoY Revenue of Tysabri in ROW 2009-2014 (US$ million)

Exhibit 68: Global Revenue Comparison of Tysabri 2009-2014 (US$ million)

Exhibit 69: UCB: Product Portfolio for Inflammatory Bowel Disease

Exhibit 70: YoY Global Revenue of Cimzia 2010-2014 (US$ million)

Exhibit 71: Shire: Product Portfolio for Inflammatory Bowel Disease

Exhibit 72: YoY Global Revenue of Lialda 2010-2014 (US$ million)

Exhibit 73: AbbVie Inc.: Product Segmentation by Revenue 2013

Exhibit 74: AbbVie Inc.: Product Segmentation by Revenue  2012 and 2013 (US$ million)

Exhibit 75: AbbVie Inc.: Sales by Geography 2013

Exhibit 76: Biogen Idec: Business Segmentation by Revenue 2013

Exhibit 77: Biogen Idec: Geographical Segmentation by Revenue 2013

Exhibit 78: Merck & Co. Inc.: Business Segmentation by Revenue 2013

Exhibit 79: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 80: Merck & Co. Inc.: Sales by Geography 2013

Exhibit 81: Shire: Geographical Segmentation by Revenue 2013

Exhibit 82: UCB: Product Segmentation by Revenue 2013

Exhibit 83: UCB: Product Segmentation by Revenue 2012 and 2013 (US$ million)

Exhibit 84: UCB: Geographical Segmentation by Revenue 2013




...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 3000
Five User: US $ 3500
Site User: US $ 4500
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top